Vivimed Labs Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 557.4 million compared to INR 565.2 million a year ago. Revenue was INR 557.93 million compared to INR 561.61 million a year ago. Net loss was INR 183.12 million compared to INR 236.82 million a year ago.
For the nine months, sales was INR 1,500.69 million compared to INR 1,761.55 million a year ago. Revenue was INR 1,503.54 million compared to INR 176,854 million a year ago. Net loss was INR 625.46 million compared to INR 493.17 million a year ago.